Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

During oral arguments, the defendants contended that the plaintiffs could not support their allegations that Novo Nordisk and ...

The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout ...

Novo Nordisk A/S slumped after a pill from rival Eli Lilly & Co. helped patients shed weight and control blood sugar about as ...

Guggenheim’s Seamus Fernandez cut his rating on Novo Nordisk stock to Hold from Buy on Thursday, as did Evan David Seigerman ...

Quatro dos 12 medicamentos incluídos na nova norma têm indicação para o combate ao sobrepeso, razão que os popularizou como ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

UBT251 is different from Novo Nordisk’s current drugs like Ozempic and Wegovy. The drug combines GLP-1 and GIP, which lower appetite and blood sugar, with glucagon, which helps prevent ...

As a pioneer in diabetes care, Novo Nordisk NVO claims 34% of the USD 80 ... negotiation for their key drug semaglutide, Wegovy/Ozempic/Rybelsus, in 2027 - it’s not clear how far the Trump ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand ... including GLP-1 medicines like Ozempic and Wegovy, Novo said in a Portuguese-language press ...

A farmacêutica Novo Nordisk vai investir R$ 6,4 bilhões na expansão de sua fábrica em Montes Claros (MG), até 2028, para ampliar a capacidade de produção das enzimas utilizadas no tratamento de ...

A empresa é dona das marcas de grande sucesso Ozempic, Wegowy e Rybelsus, voltadas para esse mercado, categoria chamada de medicamentos análogos de GLP-1. "A Novo Nordisk está agora anunciando ...